Support: +91-22-61011756 /
1. Boolean Searches :

i. AND - Shows results where both terms on either side of the 'AND' operator are present. 'AND' must be in upper case. For example search term - delhi AND metro result - It will return records in which 'delhi' as well as 'metro' both are present.

ii. OR - Shows results where either term (or both terms) is present. 'OR' must be in upper case. For example search term - delhi OR metro result - It will return records in which either 'delhi' or 'metro' or both are present

2. Proximity Searches

A proximity search looks for terms that are within a specific distance from one another. For example, search term - 'delhi metro'~10 result - It will search for records where 'delhi' and 'metro' are found within 10 words of each other

3. Phrase searches

You can search phrases using double quotes. for e.g. 'delhi metro' result - It will return records where 'delhi metro' phrase is found.

Shilpa Medicare ties up with Cadila Healthcare for production of ZyCoV-D vaccine

Friday, 24 Sep 2021
Share this on :
Shilpa Medicare (SML), via its wholly-owned subsidiary Shilpa Biologicals (SBPL), has entered into a definitive agreement with Cadila Healthcare (CHL) for production-supply of the ZyCov-D vaccine drug substance from its integrated Biologics research and development (R&D)-cum manufacturing centre at Dharwad, Karnataka.
The targeted production of the ZyCoV-D vaccine from this facility will be mutually agreed upon by both parties.
ZyCov-D is the first DNA plasmid vaccine in the world for human use developed indigenously by CHL against the COVID-19 virus. It is also the first COVID-19 vaccine for adolescents in 12-18 age group, besides the adult population and is a needle-free vaccine administered using The PharmaJet a needle-free applicator, which ensures painless intradermal vaccine delivery. 
CHL will transfer the ZyCoV-D technology to SBPL. Under the agreement, SBPL will be responsible for manufacture of the drug substance of the vaccine, while CHL is responsible for filling/packaging/ distribution/ marketing of the vaccine in its marketing territories. 
The biologics business has been identified as a strategic growth engine by SML and has made significant investments in setting up a high-end, flexible biologics facility in SBPL. 
This facility at Dharwad will cater to the requirements of the fast-growing biologics field that includes the DNA vaccine, adenoviral, subunit vaccines, monoclonal antibodies and fusion proteins.
Post Your Comments


Sign up to start your trial access

Are you...


Free access to Project News and Analysis

Project and Tender Alert in your mailbox

Explore the largest Database on Projects for free

Be part of Online Projects Community

User login
Start Exploring

Subscribe to any of our premium plans to

Access to complete information on 43000+ projects

Use our Notification service for instant update on projects and tenders

Closely monitor your opportunities with "WORKSPACE"

Use our online platform for promotions of your products and services